Safety evaluation of outpatient ifosfamide regimens in adult sarcoma patients [0.03%]
成人恶性肿瘤日间医疗异环磷酰胺方案的安全性分析
Kevin K Cheng,Vanessa Copeland,Angel Liu et al.
Kevin K Cheng et al.
Introduction: Transitioning historically inpatient chemotherapy regimens to outpatient administration can reduce hospital stays, resource use, and healthcare expenditures while improving patient quality of life. However, ...
Response to letter to the editor: A novel decision tree for performing risk assessments of biologics in a health-system setting [0.03%]
致编辑部的信的回应：在医疗系统环境下对生物制剂进行风险评估的新决策树模型
Zoe Ngo,Scott Mayeda,Stacey Yu et al.
Zoe Ngo et al.
Revisiting predictors of high-dose methotrexate related severe nephrotoxicity in children with acute lymphoblastic leukemia [0.03%]
儿童急性淋巴细胞白血病高剂量化疗致重度肾毒性的预测因素研究
Chane Choed-Amphai,Jiraporn Khorana,Lalita Sathitsamitphong et al.
Chane Choed-Amphai et al.
IntroductionAcute lymphoblastic leukemia (ALL) is the most common childhood cancer, and high-dose methotrexate (HDMTX) is a key chemotherapeutic agent. HDMTX can cause nephrotoxicity. This study aimed to identify prognostic indicators of HD...
Chamomile mouthwash for prevention of chemotherapy-induced oral mucositis: A prospective cohort study in a pharmacist-led supportive care setting [0.03%]
茶树口含液预防化疗引起的口腔黏膜炎：药师支持治疗环境下的前瞻性队列研究
Imane Benmoussa,Salma Rokki,Samira Hassoune et al.
Imane Benmoussa et al.
Chemotherapy-induced oral mucositis (OM) is a common and distressing complication of cancer treatment, significantly impacting patients' quality of life. Chamomile (Matricaria recutita L.), known for its anti-inflammatory and wound-healing ...
Comparing relative dose intensity of weekly nab-paclitaxel regimens in early breast cancer: A retrospective study at a large academic outpatient cancer center [0.03%]
早期乳腺癌每周纳米白蛋白结合型紫杉醇方案相对剂量强度的比较：大型学术性门诊肿瘤中心的回顾性研究
Kendra Gee-Rodriguez,Jina Yun,Arianne Duong et al.
Kendra Gee-Rodriguez et al.
IntroductionNational guidelines for breast cancer support substitution with nab-paclitaxel for paclitaxel or docetaxel due to medical necessity.1 This study aimed to assess for correlation between weekly nab-paclitaxel dose and relative dos...
The impact of growth factor utilization on infection risk in patients receiving bispecific monoclonal antibodies [0.03%]
生长因子使用对接受双特异性单克隆抗体治疗患者的感染风险的影响
Yong Jun Bae,Houry Leblebjian,Robert Redd et al.
Yong Jun Bae et al.
BackgroundBispecific monoclonal antibodies (BsAbs) are utilized in patients with relapsed or refractory multiple myeloma (MM) and light chain amyloidosis (AL amyloidosis) but are associated with high rates of neutropenia and infection. Gran...
Physicochemical and microbiological evaluation of dexamethasone-based mouthwash formulations [0.03%]
地塞米松含漱液配方的理化和微生物评价
Nour Jegham,Rania Rassas,Sarra Mahfoudhi et al.
Nour Jegham et al.
IntroductionOral mucositis is a common and painful side effect of chemotherapy and radiotherapy in cancer patients, significantly impairing their quality of life and adherence to treatment. Although dexamethasone is recognized for its anti-...
FLAG-Ida-Venetoclax vs CLIA-venetoclax for relapsed and refractory AML during a fludarabine shortage: A single center experience [0.03%]
FLAG-伊达比星-维奈克拉方案与CLIA-维奈克拉方案治疗复发/难治AML（诱导期氟达拉滨短缺）的单中心疗效观察
Jose Tinajero,Dat Ngo,Brian Lee et al.
Jose Tinajero et al.
ObjectiveIntensive chemotherapy combinations with venetoclax are being used more frequently for acute myeloid leukemia (AML). In May 2022, a critical shortage of fludarabine prompted cladribine substitution at several institutions in the Un...
Grace Morrison,Lisa M Holle
Grace Morrison
To review pharmacology, pharmacokinetics, therapeutic use, product safety/description and perspectives on use of lutetium Lu 177 vipivotide tetraxetan in patients with metastatic castration-resistant prostate cancer (mCRPC). Data sources: A...
Antimicrobial prophylaxis in pediatric patients with leukemia: Reducing incidence of febrile neutropenia episodes and bloodborne infections [0.03%]
儿童白血病患者抗菌药物预防的临床应用减少发热性中性粒细胞减少症发作和血流感染发生率的研究
Rachel Creighton,Zara Forbrigger,Jeannette Comeau et al.
Rachel Creighton et al.
IntroductionInfectious complications are a leading cause of morbidity and mortality in pediatric leukemia, particularly during intensive chemotherapy. Febrile neutropenia (FN), bacteremia, and fungemia are common and potentially life-threat...